Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments

INTRODUCTION: Glioblastoma multiforme (GBM) constitutes one of the deadliest tumors to afflict humans, although it is still considered an orphan disease. Despite testing multiple new and innovative therapies in ongoing clinical trials, the median survival for this type of malignancy is less than two...

Descripción completa

Detalles Bibliográficos
Autores principales: Soler, David C., Kerstetter-Fogle, Amber, McCormick, Thomas S., Sloan, Andrew E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Topic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714623/
https://www.ncbi.nlm.nih.gov/pubmed/34825292
http://dx.doi.org/10.1007/s11060-021-03902-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714623/
https://www.ncbi.nlm.nih.gov/pubmed/34825292
http://dx.doi.org/10.1007/s11060-021-03902-8

Ejemplares similares